Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

171716 Press Releases
DateTitleCompany
08 Aug 16 Sobi’s CEO divests a portion of shares Published by
GlobeNewswire
08 Aug 16 AB Science announces that Masitinib receives from European Medicines Agency (EMA) Orphan Drug Designation in the European Union for Amyotrophic Lateral Sclerosis (ALS) Published by
GlobeNewswire
08 Aug 16 OpGen Announces Completion of the Intermountain Healthcare Retrospective MDRO Health Outcome Study Published by
GlobeNewswire
08 Aug 16 Delisting of Meda Aktiebolag (publ) Published by
GlobeNewswire
08 Aug 16 Proteostasis Therapeutics Achieves Preclinical Milestone in Astellas Pharma Collaboration Published by
GlobeNewswire
08 Aug 16 Proteostasis Therapeutics Announces Key Leadership Appointments Published by
GlobeNewswire
08 Aug 16 AB Science announces that Masitinib receives from European Medicines Agency (EMA) Orphan Drug Designation in the European Union for Amyotrophic Lateral Sclerosis (ALS) AB Science,
Published by
GlobeNewswire
08 Aug 16 Spherix Issues Shareholder Update Spherix Incorporated,
Published by
PR Newswire
08 Aug 16 Walnuts a key food to improve metabolism in obese mice Oregon State University,
Published by
PR Newswire
08 Aug 16 FDA Approves the Next Generation ActiveCare® Medical Compression Systems (MCS),
Published by
PR Newswire
08 Aug 16 NEC Launches SmartScan™ - Livescan Made Smart! NEC Corporation of America,
Published by
Business Wire
08 Aug 16 Multiplex Assays Market Worth USD 3.76 Billion by 2021 - Key Players are Abcam PLC, Illumina & Merck KGAA - Research and Markets Research and Markets,
Published by
Business Wire
08 Aug 16 Tresiba® (insulin degludec) is now available through NHS Scotland for adults living with diabetes Novo Nordisk,
Published by
Four Health Communications
08 Aug 16 SCYNEXIS, Inc. Reports Second Quarter 2016 Financial Results and Provides Company Update Published by
GlobeNewswire
08 Aug 16 K2M Group Holdings, Inc. Announces Pricing of Private Offering of $50 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes due 2036 Published by
GlobeNewswire
08 Aug 16 PhaseBio Announces Dosing of First Patients in Two-Part Phase 2a Study of PB1046 in Cardiopulmonary Disorders Published by
GlobeNewswire
08 Aug 16 Rexahn Pharmaceuticals Reports Second Quarter 2016 Financial and Operational Results Published by
GlobeNewswire
08 Aug 16 Coherus BioSciences Announces Positive Topline Phase Three Results for CHS-1420 (Humira® Biosimilar Candidate) in Patients with Psoriasis Published by
GlobeNewswire
08 Aug 16 Grand Opening of Cincinnati Children's/UC Health Proton Therapy Center Cincinnati Children's Hospital Medical Center,
Published by
PR Newswire
08 Aug 16 UMass Memorial Health Care Selects Agfa HealthCare's Enterprise Imaging Solution Agfa HealthCare,
Published by
PR Newswire
08 Aug 16 TearScience® Names Edward J. Holland, MD to Board of Directors TearScience,
Published by
PR Newswire
08 Aug 16 Medtronic Receives CE Mark for SureTune2(TM) for Deep Brain Stimulation Therapy Medtronic plc,
Published by
GlobeNewswire
08 Aug 16 Evoke Pharma Completes Credit Facility Repayment Published by
GlobeNewswire
08 Aug 16 Cellectar Biosciences to Host Conference Call on August 15 to Report Second Quarter 2016 Financial Results and Corporate Performance Published by
GlobeNewswire
08 Aug 16 Dyadic International Reports the Termination of Agreement With Sanofi Pasteur Published by
GlobeNewswire
08 Aug 16 PositiveID to Exhibit at the Military Health System Research Symposium August 15-18 Published by
GlobeNewswire
08 Aug 16 Top-Ranked U.S. Hospital Purchases its 4th STREAMWAY System Published by
GlobeNewswire
08 Aug 16 Bionik Laboratories Appoints Timothy A. McCarthy as Chief Commercialization Officer and Expands Commercial Team Published by
GlobeNewswire
08 Aug 16 Alnylam Completes Enrollment in ENDEAVOUR Phase 3 Study with Revusiran, an Investigational RNAi Therapeutic for Patients with Hereditary ATTR Amyloidosis with Cardiomyopathy (hATTR-CM) Alnylam Pharmaceuticals, Inc.,
Published by
Business Wire
08 Aug 16 Bound Tree Medical and Tri-anim Health Services to Distribute ROSC-U™ Miniature Chest Compressor Nationwide Sarnova,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.